Pharmacotherapy for anxiety disorders in children and adolescents (Q24239941)

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Fluoxetine for the treatment of childhood anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Fluoxetine in children and adolescents with OCD: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Somatic symptoms in children and adolescents with anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

School phobia: a therapeutic trial with clomipramine and short-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Evaluation of lorazepam as an oral preanaesthetic medication. A comparative double-blind study with diazepam and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

A randomized, controlled trial of oral midazolam and buffered lidocaine for suturing lacerations in children (the SLIC Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

The effect of oral midazolam on anxiety of preschool children during laceration repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Postoperative behavioral outcomes in children: effects of sedative premedication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Comparison of methods of relaxation using physiological measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Placebo-controlled trial assessing the use of oral midazolam as a premedication to conscious sedation for pediatric endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

The effectiveness of oral diazepam in anxious child dental patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Midazolam nasal spray reduces procedural anxiety in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Implementing a randomized clinical trial on a pediatric psychiatric inpatient unit at a children's hospital: the case of clonidine for post-traumatic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Do subtle neurological impairments predict treatment resistance to clomipramine in children and adolescents with obsessive-compulsive disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

The effect of fluvoxamine and behavior therapy on children and adolescents with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Efficacy of rectal midazolam for the sedation of preschool children undergoing laceration repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Does adjunctive midazolam reduce recovery agitation after ketamine sedation for pediatric procedures? A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Differential Effects of Methylphenidate on Working Memory in ADHD Children with and without Comorbid Anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

The use of oral midazolam in accident and emergency to reduce anxiety in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Quantitative analysis of sponsorship bias in economic studies of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

The DSM-IV rates of child and adolescent disorders in Puerto Rico: prevalence, correlates, service use, and the effects of impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Selective mutism and social anxiety disorder: all in the family?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

The relationship between antidepressant prescription rates and rate of early adolescent suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Risk of adverse behavioral effects with pediatric use of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Suicidality in pediatric patients treated with antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Pharmacotherapy for prevention of post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Cognitive behavioural therapy for anxiety disorders in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Separation anxiety disorder in children and adolescents: epidemiology, diagnosis and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Quality of life in the anxiety disorders: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

National trends in the treatment of attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Annotation: Pathways to care for children with mental health problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Mini-review: therapeutic drug monitoring in pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Efficacy of psychoanalysis for children with emotional disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Why sources of heterogeneity in meta-analysis should be investigated

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Life course outcomes of young people with anxiety disorders in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Psychotropic practice patterns for youth: a 10-year perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Interpreting Results and Drawing Conclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Divalproex sodium for the treatment of PTSD and conduct disordered youth: a pilot randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Therapy for youths with anxiety disorders: a second randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Sertraline treatment of 5 children diagnosed with selective mutism: a single-case research trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Preliminary studies of the reliability and validity of the children's depression rating scale

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Comparative studies of pharmacotherapy for school refusal

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Imipramine treatment of children with separation anxiety disorder

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Chronic Course of Anxiety Disorders in Children and Adolescents

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Clonazepam in childhood anxiety disorders

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Response to methylphenidate in children with ADHD and comorbid anxiety

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: a pilot study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Imipramine plus cognitive-behavioral therapy in the treatment of school refusal

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Predictors of treatment response in anxious-depressed adolescents with school refusal

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Benzoctamine and medazepam in treatment of anxiety of children and adolescents: a comparative study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

Pediatric psychopharmacology

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021

What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005170.PUB2

7 January 2021